| Objective: To investigate and compare the clinical effect on Primary Liver Cancer(PLC) after transcatheter hepatic arterial chemoembolization(TACE) treated by Modified Buganqi Method with western medicine, in order to provide a new way for further diagnosis and improvement of TCM treatment.Methods: 80 cases of PLC, were randomly divided into two group, 40 cases in control group, using western medicine (basic therapy) including the integration of operation and TACE, simple TACE and symptomatic treatment; 40 cases in treatment group by Modified Buganqi Method. Comparisons of are carried out after 3 months on effectiveness in tumor size reduction, Karnofsky functional status, quality of life, relevant clinical parameters of TCM before and after treatment.Results: There are no statistically differences in age, sex, stage of diseases, tumor size reduction, Karnofsky functional status, quality of life, and relevant clinical parameters of TCM between two groups. (P>0.05) . According to therapeutic effect evaluation standard, the effectiveness of tumor size reduction is 80% as compared to control group (72.5%). Both groups have significantly improved in Karnofsky functional status (P < 0.05). The treatment group is superior to control group in quality of life and clinical parameters of TCM (P < 0.05). There are more symptoms being relieved in treatment group than control group, such as dry mouth and backache. The treatment has a vast significant on the decrease of alpha fetoprotein. There are no differences in relevant clinical parameters in tumor immunity, liver function and blood routine tests between two groups.Conclusions: Taking modified Buganqi Method on PLC following TACE can significantly improve the quality of life, and alleviate the clinical symptoms of the patients. This indicates the relevance of the theory of liver-qi xu is rational and objective. It is recommended to be implemented.
|
PDF Full Text Request